Y-Intercept (HK)’s Alto Neuroscience ANRO Stock Holding History

Y-Intercept (HK)’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23,945	Closed	-$538K	–	2243
2026 Q1	$538K	Buy	+23,945	New	+$444K	0.01%	1246
2025 Q3	–	Sell	-38,597	Closed	-$84.9K	–	2127
2025 Q2	$84.9K	Buy	+38,597	New	+$91.8K	﹤0.01%	1544

Other funds holding ANRO

GWM

GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Y-Intercept (HK)'s ANRO Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 23,945 shares — an estimated $538K sold.

Y-Intercept (HK) first reported a position in ANRO in Q2 2025 and held it in 2 quarters. The position peaked at $538K in Q1 2026. 4 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

Y-Intercept (HK) reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 23,945 Alto Neuroscience shares in Q2 2026, an estimated $538K.
Y-Intercept (HK) first reported a position in Alto Neuroscience in Q2 2025 and held it in 2 quarters.
Y-Intercept (HK)'s Alto Neuroscience position peaked at $538K in Q1 2026.
4 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.